<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Artigos sobre Coronavírus - Revista da Farmácia</title>
	<atom:link href="https://revistadafarmacia.com.br/coronavirus/feed/" rel="self" type="application/rss+xml" />
	<link>https://revistadafarmacia.com.br/coronavirus/</link>
	<description>Publicações direcionada a empresários e profissionais do varejo farmacêutico</description>
	<lastBuildDate>Wed, 07 Dec 2022 15:46:55 +0000</lastBuildDate>
	<language>pt-BR</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://revistadafarmacia.com.br/wp-content/uploads/2018/10/cropped-favicon-revista-da-farmacia-1-32x32.png</url>
	<title>Artigos sobre Coronavírus - Revista da Farmácia</title>
	<link>https://revistadafarmacia.com.br/coronavirus/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Anvisa aprova vacinas bivalentes para reforço contra Covid-19</title>
		<link>https://revistadafarmacia.com.br/coronavirus/anvisa-aprova-vacinas-bivalentes-para-reforco-contra-covid-19/</link>
					<comments>https://revistadafarmacia.com.br/coronavirus/anvisa-aprova-vacinas-bivalentes-para-reforco-contra-covid-19/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Thu, 24 Nov 2022 11:34:40 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[Anvisa]]></category>
		<category><![CDATA[covid-19]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Vacina]]></category>
		<category><![CDATA[Vacina bivalente]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=16065</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/coronavirus/anvisa-aprova-vacinas-bivalentes-para-reforco-contra-covid-19/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Medicamento para Covid-19 é aprovado pela Anvisa para venda em farmácias</title>
		<link>https://revistadafarmacia.com.br/coronavirus/medicamento-para-covid-19-e-aprovado-pela-anvisa-para-venda-em-farmacias/</link>
					<comments>https://revistadafarmacia.com.br/coronavirus/medicamento-para-covid-19-e-aprovado-pela-anvisa-para-venda-em-farmacias/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Wed, 23 Nov 2022 12:13:05 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[covid-19]]></category>
		<category><![CDATA[Medicamento para Covid-19]]></category>
		<category><![CDATA[Paxlovid]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=16037</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/coronavirus/medicamento-para-covid-19-e-aprovado-pela-anvisa-para-venda-em-farmacias/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Anvisa autoriza comercialização de álcool líquido 70%</title>
		<link>https://revistadafarmacia.com.br/legislacao/anvisa-autoriza-comercializacao-de-alcool-liquido-70/</link>
					<comments>https://revistadafarmacia.com.br/legislacao/anvisa-autoriza-comercializacao-de-alcool-liquido-70/#respond</comments>
		
		<dc:creator><![CDATA[Raphaela Quintans]]></dc:creator>
		<pubDate>Fri, 18 Nov 2022 12:46:08 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Legislação]]></category>
		<category><![CDATA[Álcool]]></category>
		<category><![CDATA[álcool 70%]]></category>
		<category><![CDATA[álcool líquido]]></category>
		<category><![CDATA[Anvisa]]></category>
		<category><![CDATA[covid-19]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=15985</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/legislacao/anvisa-autoriza-comercializacao-de-alcool-liquido-70/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Demanda por teste de Covid-19 despenca em farmácias</title>
		<link>https://revistadafarmacia.com.br/coronavirus/demanda-por-teste-de-covid-19-despenca-em-farmacias/</link>
					<comments>https://revistadafarmacia.com.br/coronavirus/demanda-por-teste-de-covid-19-despenca-em-farmacias/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Thu, 01 Sep 2022 11:40:00 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[covid-19]]></category>
		<category><![CDATA[farmácia]]></category>
		<category><![CDATA[Teste rápido]]></category>
		<category><![CDATA[Testes Covid-19]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=14730</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/coronavirus/demanda-por-teste-de-covid-19-despenca-em-farmacias/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Pfizer submete à Anvisa pedido de uso emergencial para vacina adaptada à variante ômicron</title>
		<link>https://revistadafarmacia.com.br/coronavirus/pfizer-submete-a-anvisa-pedido-de-uso-emergencial-para-vacina-adaptada-a-variante-omicron/</link>
					<comments>https://revistadafarmacia.com.br/coronavirus/pfizer-submete-a-anvisa-pedido-de-uso-emergencial-para-vacina-adaptada-a-variante-omicron/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Tue, 30 Aug 2022 11:32:53 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[Anvisa]]></category>
		<category><![CDATA[covid-19]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Uso emergencial]]></category>
		<category><![CDATA[Vacina]]></category>
		<category><![CDATA[variante ômicron]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=14726</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/coronavirus/pfizer-submete-a-anvisa-pedido-de-uso-emergencial-para-vacina-adaptada-a-variante-omicron/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Abbott lança autoteste de antígeno Panbio no Brasil</title>
		<link>https://revistadafarmacia.com.br/coronavirus/abbott-lanca-autoteste-de-antigeno-panbio-no-brasil/</link>
					<comments>https://revistadafarmacia.com.br/coronavirus/abbott-lanca-autoteste-de-antigeno-panbio-no-brasil/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Wed, 20 Jul 2022 12:15:00 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[Abbott]]></category>
		<category><![CDATA[Antígeno]]></category>
		<category><![CDATA[Autoteste]]></category>
		<category><![CDATA[covid-19]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=13991</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/coronavirus/abbott-lanca-autoteste-de-antigeno-panbio-no-brasil/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Moderna anuncia vacina mais eficiente contra variante Ômicron</title>
		<link>https://revistadafarmacia.com.br/coronavirus/moderna-anuncia-vacina-mais-eficiente-contra-variante-omicron/</link>
					<comments>https://revistadafarmacia.com.br/coronavirus/moderna-anuncia-vacina-mais-eficiente-contra-variante-omicron/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Thu, 30 Jun 2022 13:30:00 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[ômicron]]></category>
		<category><![CDATA[Vacina Covid-19]]></category>
		<category><![CDATA[Zodiac]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=13754</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/coronavirus/moderna-anuncia-vacina-mais-eficiente-contra-variante-omicron/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Autoteste para Covid-19 da Vyttra Diagnósticos chega às farmácias</title>
		<link>https://revistadafarmacia.com.br/coronavirus/autoteste-para-covid-19-da-vyttra-diagnosticos-chega-as-farmacias/</link>
					<comments>https://revistadafarmacia.com.br/coronavirus/autoteste-para-covid-19-da-vyttra-diagnosticos-chega-as-farmacias/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Thu, 23 Jun 2022 13:30:00 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[Autoteste]]></category>
		<category><![CDATA[covid-19]]></category>
		<category><![CDATA[Vyttra Diagnósticos]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=13817</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/coronavirus/autoteste-para-covid-19-da-vyttra-diagnosticos-chega-as-farmacias/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>MedLevensohn anuncia autoteste contra Covid-19 com precisão de 97,5%</title>
		<link>https://revistadafarmacia.com.br/saude/medlevensohn-anuncia-autoteste-contra-covid-19-com-precisao-de-975/</link>
					<comments>https://revistadafarmacia.com.br/saude/medlevensohn-anuncia-autoteste-contra-covid-19-com-precisao-de-975/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Wed, 22 Jun 2022 13:30:00 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Saúde]]></category>
		<category><![CDATA[Autoteste]]></category>
		<category><![CDATA[covid-19]]></category>
		<category><![CDATA[MedLevensohn]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=13715</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/saude/medlevensohn-anuncia-autoteste-contra-covid-19-com-precisao-de-975/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>DPSP expande vacinação contra Covid-19 para novos estados</title>
		<link>https://revistadafarmacia.com.br/coronavirus/dpsp-expande-vacinacao-contra-covid-19-para-novos-estados/</link>
					<comments>https://revistadafarmacia.com.br/coronavirus/dpsp-expande-vacinacao-contra-covid-19-para-novos-estados/#respond</comments>
		
		<dc:creator><![CDATA[Revista da Farmácia]]></dc:creator>
		<pubDate>Mon, 13 Jun 2022 12:59:56 +0000</pubDate>
				<category><![CDATA[Coronavírus]]></category>
		<category><![CDATA[Farmácia]]></category>
		<category><![CDATA[covid-19]]></category>
		<category><![CDATA[Drogarias Pacheco]]></category>
		<category><![CDATA[Drogarias São Paulo]]></category>
		<category><![CDATA[farmácias]]></category>
		<category><![CDATA[Grupo DPSP]]></category>
		<category><![CDATA[Vacinação]]></category>
		<guid isPermaLink="false">https://revistadafarmacia.com.br/?p=13725</guid>

					<description><![CDATA[]]></description>
		
					<wfw:commentRss>https://revistadafarmacia.com.br/coronavirus/dpsp-expande-vacinacao-contra-covid-19-para-novos-estados/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
